EMC Capital Management Makes New $1.62 Million Investment in UnitedHealth Group Incorporated $UNH

EMC Capital Management acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,731 shares of the healthcare conglomerate’s stock, valued at approximately $1,621,000. UnitedHealth Group makes up about 0.6% of EMC Capital Management’s investment portfolio, making the stock its 14th largest position.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. lifted its position in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. State Street Corp lifted its holdings in shares of UnitedHealth Group by 2.5% during the fourth quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock valued at $14,931,592,000 after purchasing an additional 1,119,834 shares during the last quarter. Capital World Investors increased its stake in UnitedHealth Group by 3.8% in the 4th quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock worth $7,457,723,000 after purchasing an additional 824,120 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in UnitedHealth Group by 3.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock valued at $6,215,660,000 after buying an additional 680,077 shares in the last quarter. Finally, Capital International Investors boosted its holdings in shares of UnitedHealth Group by 6.6% in the fourth quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock worth $6,158,734,000 after buying an additional 1,155,162 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Bank of America restated a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 20th. UBS Group boosted their target price on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Piper Sandler set a $477.00 price target on UnitedHealth Group in a report on Thursday, July 16th. BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a research note on Tuesday, July 21st. Finally, Barclays lifted their target price on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research note on Monday, July 20th. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare plans to eliminate prior-authorization requirements for approximately 1,700 treatments and services, targeting the removal of approval requirements for 30% of healthcare services by year-end. The change could reduce administrative friction for patients and providers while preserving the insurer’s focus on managing medical costs. UnitedHealthcare to drop prior authorization requirements
• Positive Sentiment: Wall Street’s average brokerage recommendation for UnitedHealth remains equivalent to a Buy, indicating that analysts generally view the company’s long-term earnings and business resilience favorably. However, the usefulness of consensus ratings may be limited because sell-side recommendations often skew optimistic. Brokers Suggest Investing in UnitedHealth
• Neutral Sentiment: After gaining 31.8% over the past year, UnitedHealth’s valuation appears neither clearly cheap nor clearly excessive. Investors are weighing the company’s quality and resilience against recent share-price softness and regulatory developments, suggesting that further upside may depend on continued earnings execution. UnitedHealth Stock May Look Reasonable Despite IRS Tax Scrutiny
• Negative Sentiment: IRS tax scrutiny introduces regulatory uncertainty and could weigh on investor confidence, even as the stock’s valuation is viewed as reasonable by some analysts. The issue may limit enthusiasm until its potential financial impact becomes clearer. UnitedHealth Stock May Look Reasonable Despite IRS Tax Scrutiny

Insider Buying and Selling

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 0.9%

NYSE UNH opened at $399.67 on Thursday. The company has a market capitalization of $358.74 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm’s fifty day simple moving average is $412.56 and its 200-day simple moving average is $363.18.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the previous year, the company posted $4.08 earnings per share. The business’s quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.